Viatris (NASDAQ: VTRS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Viatris (NASDAQ: VTRS) through any online brokerage.
There are no as such competitors for Viatris.
The latest price target for Viatris (NASDAQ: VTRS) was reported by Goldman Sachs on Thursday, May 12, 2022. The analyst firm set a price target for 11.00 expecting VTRS to fall to within 12 months (a possible -3.76% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Viatris (NASDAQ: VTRS) is $11.43 last updated Today at May 24, 2022, 6:42 PM UTC.
A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on June 16, 2022 to stockholders of record on May 23, 2022.
Viatris’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Viatris.
Viatris is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.